And these decreased expressions of the target genes resulted in impaired fatty acid transport (DBI and FABP1) and oxidation (CYP4A1), which contributed to fatty acid accumulation in the NAFLD liver. Here, DBI is linked to metabolic dysfunction-associated steatotic liver disease.